The NIH RECOVER Initiative aims to identify risks contributing to post-acute sequelae of SARS-CoV-2 infection, and approaches for treatment and prevention.

A recent survey shows a significant number of insurance providers cover diagnostic lab tests for Valley fever, according to researchers.

Researchers targeted a common sodium ion channel to reverse pain and saw positive results that could lead to a non-addictive solution to treat pain.

Native and Indigenous women had a higher percentage of mastectomy and a lower percentage of lumpectomy compared with white women.

Researchers hope that finding a connection between carotid disease and Alzheimer's could provide a new pathway for preventing dementia.

A team led by Valley Fever Center for Excellence researchers successfully tested a vaccine for dogs, with two doses providing high levels of protection.

A newly discovered mechanism for controlling blood vessel growth in tumors points to possible strategies for developing new therapeutic interventions to overcome drug resistance.

Researchers are studying existing therapies and those in clinical trials to pinpoint the most effective medications for concussion-related headaches.

Researchers in the Comprehensive Pain and Addiction Center have found that terpenes mimic cannabinoids and produce similar pain-relieving effects.

A UArizona College of Medicine - Tucson study aims to reduce relapse rates of recently quit smokers by training them to help others quit smoking.